All Posts By

Jon Kleinman

Blogs

Generic To Branded Pharma: Part IV — Results

In Parts I, II, and III of our case study, we outlined the challenges faced by a drug company who wanted to be a bigger player in the generic...
Blogs

Forces That Thwart Innovation: Part IV – Myopia

In our previous posts, we discussed how to unhook yourself — and your company — from the forces of corporate gravity in order to get big ideas off...
Blogs

Forces that Thwart Innovation: Part III – Corporate Immune System

In our previous post, we discussed how to unhook yourself — and your company — from the forces of corporate gravity in order to get big...
Blogs

Avoid Falling Victim To The Pitfalls Of Ineffective Teams

It is said that no man is an island, and in the case of top-performing companies, no singular employee overshadows the power and effectiveness of...
Blogs

The Elusive “Corporate Culture Conundrum”

More and more, executives are focusing their energy (as well as their resources) on corporate culture. While the reasons for their interest are clear –...
Blogs

Addressing “Facts” As Your Organization Sees Them

There’s a great scene in the original Men in Black movie that occurs shortly after Will Smith’s character discovers aliens really do exist. Tommy Lee Jones’ Agent...
Blogs

Innovating While Staying Compliant

Regulations tend to put a stranglehold on innovating, setting up roadblocks that require more work, more capital investment, and more time. However, innovation leadership entails...
Blogs

The Case For Accountability

I am always intrigued by examining two competing companies – same industry, similar in size, essentially operating within the same business model – that produce...
Blogs

Fear Factor: What Keeps Organizations Stuck In “Business As Usual”?

I recently sat across from a senior executive at a well-known, global company and he told me, “We are not interested in breakthroughs–we are happy...
Blogs

What a Recession Taught Enterprises About Complacency

It’s easy to fall into business-as-usual mode when the economy is strong. Pursue the low-hanging fruit and the path to least resistance, and something good will...
Blogs

It’s Not All In The Medicine: The Human Factor Of Drug Development

In the pharmaceutical industry, the odds of successfully bringing a drug compound from discovery, through all phases of development, to submission and ultimately approval are...
Blogs

Avoiding The Landmines Of Process Redesign

“Be ready to handle twice as much throughput and activity in the next 3 years with roughly the same number of people.” That was the mandate...

Subscribe to Insigniam Quarterly.

Get complimentary delivery anywhere in the world, plus the full digital experience.

SUBSCRIBE NOW